Involving our community
Our community is informed and knowledgeable about current research projects into the cause(s) of and treatments for these conditions.
Search results
Our community is informed and knowledgeable about current research projects into the cause(s) of and treatments for these conditions.
In April 2022 we joined with another seven leading sight loss organisations to make a public commitment to increasing the number of blind and partially sighted people employed within our sector, including at senior management level.
High quality information on genetic testing and counselling for families affected by inherited sight loss is now available in one place thanks to the launch of an innovative new website, Unlock Genetics.
Retina UK has a number of online support resources which we offer via social media.
We can provide all the support your organisation needs to work with us; from ideas to practical support and materials. The Retina UK team will help your contribution be as fun and rewarding as possible.
The latest podcast from Retina UK.
Ocugen’s gene therapy candidate, OCU410ST, is an experimental treatment designed to slow vision loss in Stargardt disease, an inherited retinal disease (IRD) with no approved therapies currently.
Join our upcoming webinar to hear about our Information and Support Coordinator, Mark Baxter's, holiday in Las Vegas.
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Russ was diagnosed with Choroideremia at the age of 11, after visiting caves in Spain and not being able to see anything.